Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy

<p>Abstract</p> <p>Background</p> <p>Acinar cell carcinoma (ACC) represents only 1–2% of pancreatic cancers and is a very rare malignancy. At the time of diagnosis only 50% of the tumors appear to be resectable. Reliable data for an effective adjuvant or neoadjuvant tre...

Full description

Bibliographic Details
Main Authors: Dobrowolski Frank, Stroszczynski Christian, Dittert Dag D, Rückert Felix, Distler Marius, Kersting Stephan, Grützmann Robert
Format: Article
Language:English
Published: BMC 2009-02-01
Series:World Journal of Surgical Oncology
Online Access:http://www.wjso.com/content/7/1/22
_version_ 1818758598660980736
author Dobrowolski Frank
Stroszczynski Christian
Dittert Dag D
Rückert Felix
Distler Marius
Kersting Stephan
Grützmann Robert
author_facet Dobrowolski Frank
Stroszczynski Christian
Dittert Dag D
Rückert Felix
Distler Marius
Kersting Stephan
Grützmann Robert
author_sort Dobrowolski Frank
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Acinar cell carcinoma (ACC) represents only 1–2% of pancreatic cancers and is a very rare malignancy. At the time of diagnosis only 50% of the tumors appear to be resectable. Reliable data for an effective adjuvant or neoadjuvant treatment are not available.</p> <p>Case presentation</p> <p>A 65-year old male presented with obstructive jaundice and non-specific upper abdominal pain. MRI-imaging showed a tumor within the head of the pancreas concomitant with Serum-Lipase and CA19-9. During ERCP, a stent was placed. Endosonographic fine needle biopsy confirmed an acinar cell carcinoma. Laparotomy presented an locally advanced tumor with venous infiltration that was consequently deemed unresectable. The patient was treated with five cycles of 5-FU monotherapy with palliative intention. Chemotherapy was well tolerated, and no severe complications were observed. Twelve months later, the patient was in stable condition, and CT-scanning showed an obvious reduction in the size of the tumor. During further operative exploration, a PPPD with resection of the portal vein was performed. Histopathological examination gave evidence of a diffuse necrotic ACC-tumor, all resection margins were found to be negative. Eighteen months later, the patient showed no signs of recurrent disease.</p> <p>Conclusion</p> <p>ACC responded well to 5-FU monochemotherapy. Therefore, neoadjuvant chemotherapy could be an option to reduce a primarily unresectable ACC to a point where curative resection can be achieved.</p>
first_indexed 2024-12-18T06:29:23Z
format Article
id doaj.art-18258538b8234c35a8a9f8789c5178c4
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-12-18T06:29:23Z
publishDate 2009-02-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-18258538b8234c35a8a9f8789c5178c42022-12-21T21:17:56ZengBMCWorld Journal of Surgical Oncology1477-78192009-02-01712210.1186/1477-7819-7-22Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapyDobrowolski FrankStroszczynski ChristianDittert Dag DRückert FelixDistler MariusKersting StephanGrützmann Robert<p>Abstract</p> <p>Background</p> <p>Acinar cell carcinoma (ACC) represents only 1–2% of pancreatic cancers and is a very rare malignancy. At the time of diagnosis only 50% of the tumors appear to be resectable. Reliable data for an effective adjuvant or neoadjuvant treatment are not available.</p> <p>Case presentation</p> <p>A 65-year old male presented with obstructive jaundice and non-specific upper abdominal pain. MRI-imaging showed a tumor within the head of the pancreas concomitant with Serum-Lipase and CA19-9. During ERCP, a stent was placed. Endosonographic fine needle biopsy confirmed an acinar cell carcinoma. Laparotomy presented an locally advanced tumor with venous infiltration that was consequently deemed unresectable. The patient was treated with five cycles of 5-FU monotherapy with palliative intention. Chemotherapy was well tolerated, and no severe complications were observed. Twelve months later, the patient was in stable condition, and CT-scanning showed an obvious reduction in the size of the tumor. During further operative exploration, a PPPD with resection of the portal vein was performed. Histopathological examination gave evidence of a diffuse necrotic ACC-tumor, all resection margins were found to be negative. Eighteen months later, the patient showed no signs of recurrent disease.</p> <p>Conclusion</p> <p>ACC responded well to 5-FU monochemotherapy. Therefore, neoadjuvant chemotherapy could be an option to reduce a primarily unresectable ACC to a point where curative resection can be achieved.</p>http://www.wjso.com/content/7/1/22
spellingShingle Dobrowolski Frank
Stroszczynski Christian
Dittert Dag D
Rückert Felix
Distler Marius
Kersting Stephan
Grützmann Robert
Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy
World Journal of Surgical Oncology
title Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy
title_full Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy
title_fullStr Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy
title_full_unstemmed Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy
title_short Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy
title_sort curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy
url http://www.wjso.com/content/7/1/22
work_keys_str_mv AT dobrowolskifrank curativeresectionofaprimarilyunresectableacinarcellcarcinomaofthepancreasafterchemotherapy
AT stroszczynskichristian curativeresectionofaprimarilyunresectableacinarcellcarcinomaofthepancreasafterchemotherapy
AT dittertdagd curativeresectionofaprimarilyunresectableacinarcellcarcinomaofthepancreasafterchemotherapy
AT ruckertfelix curativeresectionofaprimarilyunresectableacinarcellcarcinomaofthepancreasafterchemotherapy
AT distlermarius curativeresectionofaprimarilyunresectableacinarcellcarcinomaofthepancreasafterchemotherapy
AT kerstingstephan curativeresectionofaprimarilyunresectableacinarcellcarcinomaofthepancreasafterchemotherapy
AT grutzmannrobert curativeresectionofaprimarilyunresectableacinarcellcarcinomaofthepancreasafterchemotherapy